|
Jun 30
|
AbbVie to buy Capstan for up to $2.1 billion in immunology push
|
|
Jun 30
|
Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?
|
|
Jun 29
|
H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results
|
|
Jun 27
|
Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug
|
|
Jun 26
|
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call
|
|
Jun 24
|
Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit
|
|
May 27
|
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
|
|
May 26
|
3 Top Growth Stocks to Buy in the Second Half of 2025
|
|
May 24
|
2 Monster Growth Stocks to Buy and Hold for 10 Years
|
|
May 21
|
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
|
|
May 6
|
Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash
|
|
May 6
|
S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop
|
|
May 6
|
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
|
|
May 6
|
Uber-Pony AI partnership, EVgo boost, Vertex earnings miss
|
|
May 6
|
Stock Market Today: Dow Jones, S&P 500 Losses Climb; These Two New Issues Jump While Palantir Tanks (Live Coverage)
|
|
May 6
|
Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge
|
|
May 6
|
Vertex Pharmaceuticals Stock Is Tumbling After Earnings. Here’s Why.
|
|
May 6
|
VRTX's Q1 Earnings Lag Estimates, 2025 Revenue View Tightened
|
|
May 6
|
Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More
|
|
May 6
|
Vertex Pharmaceuticals Stock Sinks as Costs Soar
|